Clinical Trials Directory

Trials / Terminated

TerminatedNCT04357353

The Role of Platelet Rich Plasma for Erectile Dysfunction

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
13 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
Male
Age
50 Years – 80 Years
Healthy volunteers
Accepted

Summary

Purpose of Study: This randomized controlled trial investigates the role that platelet rich plasma injections into the penis may play to improve erectile function in men with erectile dysfunction.

Detailed description

Eligibility: Men with erectile dysfunction. Ages 50-80. International Index of Erectile Function score of mild (17-21/25) or moderate (8-16/25). Intervention and Evaluation:Men who consent to join the trial will be randomized to receive either a single injection PRP or saline to the penis. All patients will have blood drawn in clinic the day of injection. Those randomized to PRP arm will have their own blood prepared and separated into the PRP. This solution of their own blood will be injected back into the penis. Follow Up: Men will be evaluated at 1 , 3, and 6 months after the injections and then asked to complete the IIEF by phone or by electronic means

Conditions

Interventions

TypeNameDescription
BIOLOGICALPlatelet rich plasmaPRP will be used in the experimental arm.
OTHERPlacebo Sham Injectionsham injection

Timeline

Start date
2021-04-01
Primary completion
2022-11-02
Completion
2022-11-02
First posted
2020-04-22
Last updated
2023-08-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04357353. Inclusion in this directory is not an endorsement.